The same physician can be a Tier 1 target for one model and a hard pass for another.
I ran two sourcing engagements in parallel recently.
Same general specialty. Different buyer models.
When I started building the signal layer for each, the target universe started to split in a way that would not have shown up in a generic screen.
Physicians who looked attractive for one buyer would have been screened out entirely for the other.
The data was not the issue.
The underlying buyer model was different.
The signal stack you build is downstream of your model, not your market.
From what I’ve seen, a lot of healthcare M&A sourcing still starts with what I’d call the classic platform acquisition profile: a physician-owner who is nearing a transition, but still engaged enough to carry the practice through the first few years post-close.
The signals usually cluster around the same pattern:
Physician in their mid-to-late 50s
No obvious succession plan
Partner departures or provider movement
Lease renewal pressure
Reimbursement headwinds
Competitor platform activity nearby
Those are exit-proximity signals.
They help identify when a physician may be approaching the end of independent ownership, either by choice or by pressure.
But the better traditional acquirers are usually not looking for someone who is fully checked out. That is where the screen can get too blunt.
In high-touch specialties, physician reputation is sticky.
Patient and referral relationships do not transfer cleanly to a new operator.
A strong acquisition target is often somewhere in the middle: motivated enough to consider a transaction, but still engaged enough to help bridge the first 12 to 36 months post-close while the platform builds its own referral infrastructure.
That is the profile the signal stack is trying to find.
Momentum slowing, but not gone.
Now flip the model.
In JV-style structures I’ve seen, the economics only work if the physician keeps building after close.
The physician stays in the business, keeps operating, and often keeps meaningful upside.
That changes what you are screening for.
A physician approaching 60 with a succession gap may look attractive in a cash-out model.
For a JV buyer, that same profile can raise the wrong questions.
Is this physician still trying to build?
Do they want a partner, or do they want an exit?
Are they looking for growth capital, or are they trying to de-risk the next chapter?
The physician who fits a JV model is usually mid-career, growth-oriented, platform-naive, and not looking for maximum liquidity at close.
They want capital, infrastructure, and a partner who will not take the wheel.
The upside is the draw, not the check.
Same market.
Same specialty.
Different thesis.
Different target.
Where Signals Flip
The interesting part is not just that the two buyer profiles differ.
It is that the same data point can mean different things depending on the model behind the search.
Signal | Classic Platform Acquisition | JV Partnership Model |
|---|---|---|
Physician age | Later-career, approaching transition | Mid-career, still building |
Roster trajectory | Stable, shrinking, or transitioning | Stable or growing |
Recent departures | May create seller urgency | May create retention concern |
Lease pressure | Potential catalyst | Potential distraction |
Platform exposure | Can validate seller interest | May mean the window has passed |
Reimbursement pressure | Can create motivation | Can weaken the equity-upside case |
Prior inbound | Seller may be active | Buyer needs to understand selectivity |
This is why generic target lists break.
A physician who screens well for a cash-out acquisition model can be a poor fit for a physician-led JV.
And vice versa.
The screen can be technically correct and still point the team at the wrong segment of the market.
The Part That Gets Skipped
A lot of deal teams build the target universe first and decide what signals to track later.
That sequence creates problems.
Before you enrich a single NPI or build a universe, you need to define what kind of physician the buyer is actually trying to find.
Someone nearing transition, motivated by succession planning, but still engaged enough to carry volume?
Or someone still building, motivated by equity upside, and looking for a partner rather than an exit?
Those are different sourcing motions.
Different screens.
Different outreach angles.
Different conversations.
If you get that wrong, you can spend weeks building a clean target list full of the wrong doctors.
Clean data.
Wrong frame.
Wasted motion.
The market does not sort itself by buyer model.
That work has to happen before sourcing starts.
Healthcare M&AI builds thesis-calibrated sourcing systems for healthcare deal teams. If conversion is weak on a clean list, I'd look upstream at how the list was designed.
-Shawn
---
This newsletter is for informational purposes only and does not constitute investment, legal, or financial advice.